These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8425305)

  • 1. Comparative study on the proarrhythmic effects of some antiarrhythmic agents.
    Dhein S; Müller A; Gerwin R; Klaus W
    Circulation; 1993 Feb; 87(2):617-30. PubMed ID: 8425305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol unmasks class III like electrophysiological properties of norepinephrine.
    Dhein S; Gerwin R; Ziskoven U; Schott M; Rump AF; Zhao Y; Salameh A; Klaus W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):643-9. PubMed ID: 8133907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. A mapping study.
    Dhein S; Manicone N; Müller A; Gerwin R; Ziskoven U; Irankhahi A; Minke C; Klaus W
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):174-84. PubMed ID: 7990974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic marker of the cardiac action potential triangulation induced by antiarrhythmic drugs in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2022 Aug; 107(8):864-878. PubMed ID: 35561081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylsalicylic acid enhances arrhythmogeneity in a model of local ischemia of isolated rabbit hearts.
    Dhein S; Gottwald M; Gottwald E; Hohlfeld T; Salameh A; Klaus W
    Eur J Pharmacol; 1997 Nov; 339(2-3):129-39. PubMed ID: 9473126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
    Fagbemi SO; Chi L; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism by class I antiarrhythmic drugs of levcromakalim-induced relaxation in isolated rat aorta.
    Cogolludo AL; Perez-Vizcaino F; Tamargo J
    J Pharmacol Exp Ther; 1998 Oct; 287(1):81-6. PubMed ID: 9765325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of epicardial activation mapping in isolated hearts for the assessment of arrhythmogenic and antiarrhythmic drug activity.
    Dhein S; Müller A; Klaus W
    J Pharmacol Methods; 1989 Nov; 22(3):197-206. PubMed ID: 2586114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggravation of ventricular arrhythmia. A drug-induced complication.
    Podrid PJ
    Drugs; 1985; 29 Suppl 4():33-44. PubMed ID: 3924550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
    Galimberti ES; Knollmann BC
    J Mol Cell Cardiol; 2011 Nov; 51(5):760-8. PubMed ID: 21798265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF; Fabritz CL; Franz MR
    Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an antiarrhythmic drug A-2545 on canine ventricular arrhythmia models; comparison with mexiletine and flecainide.
    Xue YX; Arita J; Aye NN; Hashimoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):649-56. PubMed ID: 9879724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drug effects on premature beats are partly determined by prior cardiac activation frequency in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2020 May; 105(5):819-830. PubMed ID: 32175633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
    Osadchii OE
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of class I antiarrhythmic drugs on epicardial electrograms in dogs.
    Watanabe T; Kubota I; Yamaki M; Tachibana H; Tomoike H
    Jpn Heart J; 1999 Sep; 40(5):621-8. PubMed ID: 10888382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic agents for chronic ventricular arrhythmias.
    Nestico PF; Morganroth J
    Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.